Abstract

Ecstasy/MDMA Perceived Risk by Late Adolescents and Early Adults

Ecstasy/MDMA is usually lumped with “club drugs” which is where ecstasy is more likely to be prevalent since it comes in hand with EDM (Electronic Dance Music) and other club music and is advertised as “Molly” to be a pure form of ecstasy which is very hard to know if it contains any MDMA at all. According to a study conducted by Johnston et al., the individual’s perceived risk and harmfulness of the drug determine usage. Risk was observed during a period of time and it can be alarming when perceived risk drops because it can have unpredictable effects on new population using ecstasy/MDMA. One of the highest predictors found if a young adult would participate in the use of ecstasy is the association with other ecstasy users and the types of events attended.

Popularity of ecstasy/MDMA does not have a consistent measure of popularity since it is often changing and each risk perceived is effective to drops in popularity as well as when the risk is not seen as a big issue. During a longitudinal study Johnston et al. was able to see that while one year of high school students could have negative perceptions of a drug others could be exempt and would affect just those years of students.

One popular predictor found by Smirnov et al. was that much ecstasy use occurred under a specific type of music culture which was mainly electronic music and dance music in clubs as opposed to a diminished amount in places where there was live music. This shows that the social environment has a deep influence on the frequency that the drug is offered on individuals. This is because the basic perception of the drug is associated to be part of the electronic music scene.


Author(s):

Uriel E Salas and LaVelle Hendricks



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • International Conference on Drug Discovery, Designing and Development
    June 27-28, 2018 Vancouver, British Columbia, Canada
  • World Drug Delivery Summit
    September 24-25, 2018 (10 Plenary Forums - 1Event) Chicago, Illinois, USA
  • International Conference on Pharmaceutical Chemistry
    October 29-31, 2018 Brussels, Belgium
Flyer image

Abstracted/Indexed in

  • Chemical Abstracts Service (CAS)
  • Index Copernicus
  • Google Scholar
  • Genamics JournalSeek
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • MIAR
  • ResearchGate
  • University Grants Commission